Adenia Partners, the Mauritius-based private equity firm led by Antoine Delaporte, has agreed to acquire a majority stake in Egypts Parkville Pharmaceuticals, marking its first controlling investment in the country. The deal, signed under a definitive agreement, is subject to customary regulatory approvals and closing conditions. Financial terms were not disclosed.
Under the transaction, Adenia will buy the majority holding from pan-African private equity firm Admaius Capital Partners, alongside Parkvilles co-founders and executives, Chairman Sherif Bassiouny and Chief Executive Officer Mahmoud Farrag. The investment brings Adenia into one of Egypts fastest-expanding segments of consumer health and personal care.
Parkville broadens Egypt healthcare reach
